Brown Brothers Harriman & Co. Purchases New Position in Abrdn Healthcare Investors (NYSE:HQH)

Brown Brothers Harriman & Co. purchased a new stake in Abrdn Healthcare Investors (NYSE:HQH) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,000 shares of the financial services provider’s stock, valued at approximately $48,000.

Several other hedge funds have also recently bought and sold shares of HQH. Millstone Evans Group LLC bought a new stake in shares of Abrdn Healthcare Investors in the 4th quarter worth about $29,000. FNY Investment Advisers LLC acquired a new position in Abrdn Healthcare Investors in the fourth quarter valued at about $48,000. TD Private Client Wealth LLC bought a new stake in Abrdn Healthcare Investors during the third quarter worth about $66,000. Wealthfront Advisers LLC acquired a new stake in shares of Abrdn Healthcare Investors during the fourth quarter worth approximately $118,000. Finally, Stifel Financial Corp bought a new position in shares of Abrdn Healthcare Investors in the third quarter valued at approximately $188,000. 32.60% of the stock is currently owned by institutional investors and hedge funds.

Abrdn Healthcare Investors Price Performance

HQH stock opened at $15.85 on Thursday. The business has a fifty day moving average price of $17.25 and a 200 day moving average price of $17.52. Abrdn Healthcare Investors has a fifty-two week low of $15.73 and a fifty-two week high of $19.79.

Abrdn Healthcare Investors Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Friday, February 21st were issued a $0.57 dividend. The ex-dividend date was Friday, February 21st. This represents a $2.28 dividend on an annualized basis and a dividend yield of 14.38%.

Abrdn Healthcare Investors Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.